Edition:
India

Express Scripts Holding Co (ESRX.OQ)

ESRX.OQ on NASDAQ Stock Exchange Global Select Market

68.39USD
2:29am IST
Change (% chg)

$0.24 (+0.35%)
Prev Close
$68.15
Open
$68.00
Day's High
$68.63
Day's Low
$67.75
Volume
1,520,137
Avg. Vol
1,292,224
52-wk High
$73.52
52-wk Low
$55.80

Latest Key Developments (Source: Significant Developments)

Avista Capital Partners To Acquire Express Scripts' Subsidiary United Biosource
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Express Scripts Holding Co ::AVISTA CAPITAL PARTNERS TO ACQUIRE EXPRESS SCRIPTS' SUBSIDIARY UNITED BIOSOURCE.AVISTA CAPITAL PARTNERS TO ACQUIRE EXPRESS SCRIPTS' SUBSIDIARY UNITED BIOSOURCE.EXPRESS SCRIPTS HOLDING CO - ‍AVISTA SIGNED DEFINITIVE AGREEMENT TO ACQUIRE UNITED BIOSOURCE, A SUBSIDIARY OF CO.  Full Article

Express Scripts appoints James Havel as CFO
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Express Scripts Holding Co :Express Scripts Holding Co appoints James M. Havel chief financial officer.Express Scripts Holding Co - ‍Eric Slusser, executive vice president and chief financial officer, is leaving company​.  Full Article

Express Scripts reports Q3 GAAP earnings per share $1.46
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Express Scripts Holding Co :Express Scripts announces 2017 third quarter results.Q3 adjusted earnings per share $1.90.Q3 GAAP earnings per share $1.46.Q3 earnings per share view $1.90 -- Thomson Reuters I/B/E/S.Sees Q4 2017 adjusted earnings per share $2.03 to $2.11.Express Scripts holding co qtrly ‍adjusted claims of 343.6 million, down 1 pct​.Qtrly ‍revenues $24,683 million versus $25,410 million.Express Scripts holding-‍increasing expected 2018 retention rate for 2017 selling season, excluding impact of remaining coventry business to be above 95 percent​.Says ‍company expects to formalize plan for its enterprise value initiative by end of 2017​.Express Scripts holding-‍enterprise value initiative estimated to cost about $600 million to $650 million ,to deliver cumulative savings of nearly $1.2 billion by 2021​.Express Scripts holding-‍increased its guidance for fy 2017 adjusted earnings per diluted share from a range of $6.95 to $7.05 to a range of $6.97 to $7.05​.Says ‍adjusted earnings per diluted share for q4 of 2017 is estimated to be in range of $2.03 to $2.11​.Express Scripts holding co says ‍expects total adjusted claims for q4 of 2017 to be in range of 347 million to 363 million​.Q4 earnings per share view $2.05 -- Thomson Reuters I/B/E/S.Fy2017 earnings per share view $6.99 -- Thomson Reuters I/B/E/S.  Full Article

Express scripts to acquire Evicore Healthcare for $3.6 bln
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - Express Scripts Holding Co :Express Scripts to acquire Evicore Healthcare; accelerates company's shift to patient benefit management.Express Scripts Holding Co - deal for ‍$3.6 billion​.Express Scripts Holding Co - ‍expects acquisition to be accretive to adjusted diluted earnings per share in its first full year of operation​.Express Scripts Holding - ‍acquiring Evicore from current investors including General Atlantic, TA Associates, and Ridgemont Equity Partners​.Express Scripts Holding Co says ‍Evicore will operate as a standalone business unit within Express Scripts​.  Full Article

Express Scripts CEO Timothy Wentworth's FY 2016 total compensation $14.5 mln vs $8.5 mln
Saturday, 18 Mar 2017 

Express Scripts Holding Co : Express scripts holding co - ceo timothy wentworth's fy 2016 total compensation $14.5 million versus $8.5 million in fy 2015 - sec filing .Express scripts holding co - former ceo george paz's fy 2016 total compensation $11.9 million versus $14.8 million in fy 2015.  Full Article

Express Scripts chief medical officer says Mylan has a monopoly on the EpiPen
Friday, 26 Aug 2016 

: Express Scripts Chief Medical Officer Steve Miller On Mylan Epipen Price Hike - "Mylan could lower the price today" . Express Scripts Chief Medical Officer Steve Miller On Mylan Epipen Price Hike - Mylan has a monopoly on the epipen Further company coverage: [MYL.O ESRX.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Horizon pharma says it continues to have discussions with Express Scripts
Tuesday, 2 Aug 2016 

Horizon Pharma : Continues to have discussions with express scripts and sees potential pathway to completion of potential partnership with express scripts beginning 2017 .Recognizes express scripts published formulary exclusion list, which will take effect on january 1, 2017, includes duexis and vimovo.  Full Article

Horizon pharma says it continues to have discussions with Express Scripts
Tuesday, 2 Aug 2016 

Horizon Pharma : Continues to have discussions with express scripts and sees potential pathway to completion of potential partnership with express scripts beginning 2017 .Recognizes express scripts published formulary exclusion list, which will take effect on january 1, 2017, includes duexis and vimovo.  Full Article

Express Scripts Q2 earnings per share $1.13
Tuesday, 26 Jul 2016 

Express Scripts Holding Co : Says Q2 revenue $25.22 billion versus $25.45 billion . Sees Q3 total adjusted claims 311 million to 321 million . Year adjusted diluted eps guidance range; raises mid-point; provides 2016 third quarter guidance . Q2 earnings per share $1.13 . Q2 earnings per share view $1.57 -- Thomson Reuters I/B/E/S . Sees FY 2016 adjusted earnings per share $6.33 to $6.43 . Q2 adjusted earnings per share $1.57 . Says Q2 adjusted claims of 315.3 million . Says narrows 2016 adjusted earnings per diluted share guidance to a range of $6.33 to $6.43 . Sees Q3 adjusted diluted earnings per share $1.72 to $1.76 .FY 2016 earnings per share view $6.35; q3 earnings per share view $1.72 -- Thomson Reuters I/B/E/S.  Full Article

Deals of the day-Mergers and acquisitions

Nov 30 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Thursday: